Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Vision in children with hydrocephalus.

Susann Andersson1, Eva-Karin Persson, Eva Aring

  • 1Department of Ophthalmology, Institute of Clinical Neuroscience, The Sahlgrenska Academy of Göteborg University, Göteborg, Sweden. susann.andersson@oft.gu.se

Developmental Medicine and Child Neurology
|September 19, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Childhood ocular safety after postnatal exposure to topical dexamethasone during retinopathy of prematurity screening.

Acta ophthalmologica·2026
Same author

The NR2F1-Related 5q14.3-q21.1 deletion causing periventricular heterotopia with cerebral visual impairment: a longitudinal case report and genotype-phenotype analysis.

Frontiers in genetics·2026
Same author

External validation and updating of DIGIROP prediction models including parenteral nutrition for treatment-requiring retinopathy of prematurity in a Swedish national cohort.

BMJ open ophthalmology·2026
Same author

Long-Term Societal Costs After Births Before 24 Weeks of Gestation in Sweden.

Acta paediatrica (Oslo, Norway : 1992)·2026
Same author

Low serum sphingosine-1-phospate and its chaperone ApoM associate with retinopathy of prematurity.

Journal of lipid research·2026
Same author

Fatty Acid Supplementation and Retinopathy of Prematurity: Secondary Analysis of a Randomized Clinical Trial.

JAMA ophthalmology·2026

Surgically treated hydrocephalus in children frequently causes visual and cognitive visual dysfunction, impacting areas like depth perception and orientation. Children with myelomeningocele showed fewer visual issues.

Area of Science:

  • Ophthalmology
  • Pediatrics
  • Neurology

Background:

  • Hydrocephalus in children can lead to various ophthalmic and visual disorders.
  • Surgical treatment is common for hydrocephalus, but its impact on visual function requires detailed assessment.

Purpose of the Study:

  • To detect and quantify visual and visuoperceptual dysfunction in children with surgically treated hydrocephalus.
  • To compare visual outcomes between children with hydrocephalus (with and without myelomeningocele) and a control group.
  • To correlate visual deficits with specific diagnoses and comorbidities.

Main Methods:

  • Comprehensive ophthalmologic examinations were performed on 75 school-aged children with surgically treated hydrocephalus and 140 age- and sex-matched controls.
  • Visual acuity, refractive errors, strabismus, and cognitive visual functions were assessed.

Related Experiment Videos

  • Statistical analysis was used to compare outcomes between groups and identify correlations.

    • Main Results:

    • 83% of children with hydrocephalus exhibited visual function deficits.
    • Significant increases in visual impairment, strabismus (69%), refractive errors (67%), and cognitive visual dysfunction (59%) were observed compared to controls.
    • Children with hydrocephalus and myelomeningocele had the lowest incidence of visual disorders; those with epilepsy, cerebral palsy, or cognitive disability had the highest.

    Conclusions:

    • Surgically treated hydrocephalus is associated with a high prevalence of visual and visuoperceptual disorders in children.
    • Cognitive visual dysfunctions, including impaired depth perception and orientation, are common.
    • Early and comprehensive visual assessment is crucial for children with hydrocephalus, especially those with comorbidities.